SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040598
Filing Date
2023-11-13
Accepted
2023-11-13 16:58:44
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1704199
2 ex10-4.htm EX-10.4 42477
3 ex31-1.htm EX-31.1 9971
4 ex31-2.htm EX-31.2 9973
5 ex32-1.htm EX-32.1 4514
6 ex32-2.htm EX-32.2 4557
  Complete submission text file 0001493152-23-040598.txt   5489227

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20230930.xsd EX-101.SCH 32062
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnxt-20230930_cal.xml EX-101.CAL 39138
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnxt-20230930_def.xml EX-101.DEF 119107
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20230930_lab.xml EX-101.LAB 291504
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20230930_pre.xml EX-101.PRE 222335
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 729712
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 231399797
SIC: 2834 Pharmaceutical Preparations